NeuroPace to Host Investor Day on January 28th in New York City

Core Insights - NeuroPace, Inc. will host an Investor Day on January 28, 2025, in New York City to discuss its vision for RNS technology and future plans [1][2] - The event will feature management presentations on recent results, market strategies, and clinical development for the RNS System, along with guest speakers including clinical experts and an RNS patient [2] Company Overview - NeuroPace is a medical device company based in Mountain View, California, focused on improving the lives of individuals with epilepsy by reducing or eliminating seizures [3] - The RNS System is the first commercially available brain-responsive platform that provides personalized, real-time treatment at the source of seizures, aiming to enhance care for patients with drug-resistant epilepsy [3]